Climb Bio (CLYM) Non Operating Income (2020 - 2026)

Climb Bio has reported Non Operating Income for 7 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 33.44% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (down 19.53% YoY), and the FY2025 full-year result was $8.0 million, down 1.12% from the prior year.
• Non Operating Income for Q1 2026 stood at $1.5 million, down from $1.8 million in the prior quarter.
• The five-year high for Non Operating Income was $2.8 million in Q3 2024, with the low at -$934000.0 in Q3 2022.
• Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of $1.5 million in 2026.
• Annual changes were most pronounced in 2022 — Non Operating Income sank 7358.33% — and 2023, when it jumped 1694.44%.
• Climb Bio's Non Operating Income stood at $1.8 million in 2022, then declined by 17.35% to $1.5 million in 2023, then jumped by 68.47% to $2.5 million in 2024, then declined by 28.66% to $1.8 million in 2025, then decreased by 16.35% to $1.5 million in 2026.
• The last three Non Operating Income figures came in at $1.5 million (Q1 2026), $1.8 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.